180 related articles for article (PubMed ID: 31344747)
1. [Therapy of sialorrhea with botulinum toxin].
Jost WH; Bäumer T; Laskawi R; Spittau B; Steffen A; Winterholler M
Fortschr Neurol Psychiatr; 2019 Oct; 87(10):554-563. PubMed ID: 31344747
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Sialorrhea with Botulinum Toxin - An Update].
Jost WH; Bäumer T; Berweck S; Laskawi R; Spittau B; Steffen A; Winterholler M
Fortschr Neurol Psychiatr; 2022 May; 90(5):222-232. PubMed ID: 35453157
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin B reduces sialorrhea in parkinsonism.
Racette BA; Good L; Sagitto S; Perlmutter JS
Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
[TBL] [Abstract][Full Text] [Related]
4. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
Turk-Gonzales M; Odderson IR
Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
[TBL] [Abstract][Full Text] [Related]
5. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
[TBL] [Abstract][Full Text] [Related]
6. Sialorrhea: a management challenge.
Hockstein NG; Samadi DS; Gendron K; Handler SD
Am Fam Physician; 2004 Jun; 69(11):2628-34. PubMed ID: 15202698
[TBL] [Abstract][Full Text] [Related]
7. [Salivation after stroke].
Zalyalova ZA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):85-89. PubMed ID: 28635876
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
Tan EK
Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
[TBL] [Abstract][Full Text] [Related]
10. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
Young CA; Ellis C; Johnson J; Sathasivam S; Pih N
Cochrane Database Syst Rev; 2011 May; (5):CD006981. PubMed ID: 21563158
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Non Invasive Treatment of Sialorrhea in the Goldenhar Syndrome.
Marvulli R; Gallo GA; Mastromauro L; Dicuonzo F; Fiore P; Ianieri G; Megna M
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):397-400. PubMed ID: 29595115
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.
Steinlechner S; Klein C; Moser A; Lencer R; Hagenah J
Psychopharmacology (Berl); 2010 Jan; 207(4):593-7. PubMed ID: 19823807
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
[TBL] [Abstract][Full Text] [Related]
16. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
[TBL] [Abstract][Full Text] [Related]
17. Therapy of Sialorrhea with Botulinum Neurotoxin.
Jost WH; Bäumer T; Laskawi R; Slawek J; Spittau B; Steffen A; Winterholler M; Bavikatte G
Neurol Ther; 2019 Dec; 8(2):273-288. PubMed ID: 31542879
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of sialorrhea with botulinum toxin: an overview].
Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
[TBL] [Abstract][Full Text] [Related]
19. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
Jost WH
J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.
Toulemonde P; Maltezeanu A; Broucqsault H; Fayoux P
Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):77-81. PubMed ID: 34217684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
